Healthcare provider profile · identity verified

Shayn Collins, MD

Family Practice · STROUDSBURG, PA · NPI 1184152811

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	363	104
Amlodipine Besylate	Amlodipine Besylate	176	50
Lisinopril	Lisinopril	170	47
Levothyroxine Sodium	Levothyroxine Sodium	137	36
Gabapentin	Gabapentin	136	36
Losartan Potassium	Losartan Potassium	136	39
Albuterol Sulfate Hfa	Albuterol Sulfate	135	35
Metformin Hcl	Metformin Hcl	131	36
Metoprolol Succinate	Metoprolol Succinate	120	36
Tamsulosin Hcl	Tamsulosin Hcl	111	33
Pantoprazole Sodium	Pantoprazole Sodium	105	30
Diclofenac Sodium	Diclofenac Sodium	94	47
Furosemide	Furosemide	86	27
Metoprolol Tartrate	Metoprolol Tartrate	78	20
Eliquis	Apixaban	77	16
Trazodone Hcl	Trazodone Hcl	75	31
Rosuvastatin Calcium	Rosuvastatin Calcium	74	26
Omeprazole	Omeprazole	73	24
Jardiance	Empagliflozin	71	19
Pravastatin Sodium	Pravastatin Sodium	69	17
Zolpidem Tartrate	Zolpidem Tartrate	67	13
Fluticasone Propionate	Fluticasone Propionate	64	25
Metformin Hcl Er	Metformin Hcl	62	24
Allopurinol	Allopurinol	58	18
Sertraline Hcl	Sertraline Hcl	54	12
Simvastatin	Simvastatin	54	18
Ozempic	Semaglutide	52	18
Alprazolam	Alprazolam	48	13
Potassium Chloride	Potassium Chloride	47	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	46	suppressed
Duloxetine Hcl	Duloxetine Hcl	45	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	44	26
Carvedilol	Carvedilol	40	14
Famotidine	Famotidine	38	12
Lorazepam	Lorazepam	38	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Chlorthalidone	Chlorthalidone	35	suppressed
Paroxetine Hcl	Paroxetine Hcl	35	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Azithromycin	Azithromycin	34	32
Hydrochlorothiazide	Hydrochlorothiazide	34	11
Rybelsus	Semaglutide	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	32	suppressed
Torsemide	Torsemide	31	suppressed
Atenolol	Atenolol	30	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Clonazepam	Clonazepam	28	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Amoxicillin	Amoxicillin	26	22
Meloxicam	Meloxicam	26	suppressed
Incruse Ellipta	Umeclidinium Bromide	25	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	25	suppressed
Ropinirole Hcl	Ropinirole Hcl	25	suppressed
Valsartan	Valsartan	25	suppressed
Methylprednisolone	Methylprednisolone	24	23
Mounjaro	Tirzepatide	24	suppressed
Xarelto	Rivaroxaban	24	suppressed
Ibuprofen	Ibuprofen	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	19
Finasteride	Finasteride	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Nystatin	Nystatin	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Glimepiride	Glimepiride	20	suppressed
Diazepam	Diazepam	19	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	18	suppressed
Lidocaine	Lidocaine	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	11
Cephalexin	Cephalexin	17	12
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Epinephrine	Epinephrine	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Baclofen	Baclofen	15	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Icosapent Ethyl	Icosapent Ethyl	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Naproxen	Naproxen	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Tresiba Flextouch U-100	Insulin Degludec	14	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	14	suppressed
Glipizide	Glipizide	13	suppressed
Linzess	Linaclotide	13	suppressed
Nyamyc	Nystatin	13	suppressed
Prednisone	Prednisone	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Irbesartan	Irbesartan	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Ubrelvy	Ubrogepant	12	suppressed
Vtama	Tapinarof	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error